tiprankstipranks
Advertisement
Advertisement

SE:XVIVO Stock Latest News

XVIVO Sets April 24 Call to Present Q1 2026 Interim Report
Company AnnouncementsXVIVO Sets April 24 Call to Present Q1 2026 Interim Report
2d ago
XVIVO’s Heart Preservation Trial Shows Improved One‑Year Outcomes in European Study
PremiumCompany Announcements
XVIVO’s Heart Preservation Trial Shows Improved One‑Year Outcomes in European Study
3d ago
Xvivo Perfusion announces publication of one-year results from NIHP2019 trial
PremiumThe Fly
Xvivo Perfusion announces publication of one-year results from NIHP2019 trial
3d ago
XVIVO Perfusion Calls 2026 AGM, Proposes New Board Members and Incentive Plan
PremiumCompany Announcements
XVIVO Perfusion Calls 2026 AGM, Proposes New Board Members and Incentive Plan
1M ago
XVIVO Perfusion Updates Board Proposals Ahead of 2026 AGM
PremiumCompany Announcements
XVIVO Perfusion Updates Board Proposals Ahead of 2026 AGM
2M ago
XVIVO Perfusion nominates experienced healthcare leaders to strengthen board
PremiumCompany AnnouncementsXVIVO Perfusion nominates experienced healthcare leaders to strengthen board
2M ago
XVIVO Elevates CFO to Lead Global Strategy as It Targets U.S. Growth
Premium
Company Announcements
XVIVO Elevates CFO to Lead Global Strategy as It Targets U.S. Growth
2M ago
XVIVO Delays Q1 2026 Report to Spotlight Key U.S. Heart Study
Premium
Company Announcements
XVIVO Delays Q1 2026 Report to Spotlight Key U.S. Heart Study
2M ago
XVIVO Perfusion Balances Organ Business Growth With Heavy R&D Spend in 2025
PremiumCompany Announcements
XVIVO Perfusion Balances Organ Business Growth With Heavy R&D Spend in 2025
3M ago
XVIPF Earnings this Week: How Will it Perform?
PremiumPre-Earnings
XVIPF Earnings this Week: How Will it Perform?
3M ago
XVIVO Schedules Conference Call for 2025 Year-End Results
PremiumCompany Announcements
XVIVO Schedules Conference Call for 2025 Year-End Results
3M ago
XVIVO CEO to Spotlight Organ-Transplant Technology at J.P. Morgan Healthcare Conference
PremiumCompany Announcements
XVIVO CEO to Spotlight Organ-Transplant Technology at J.P. Morgan Healthcare Conference
3M ago
Xvivo Perfusion AB’s Mixed Earnings Call: Growth Amid Challenges
PremiumCompany AnnouncementsXvivo Perfusion AB’s Mixed Earnings Call: Growth Amid Challenges
6M ago
Xvivo Perfusion upgraded to Buy from Hold at Danske Bank
Premium
The Fly
Xvivo Perfusion upgraded to Buy from Hold at Danske Bank
6M ago
XVIVO Perfusion AB Reports Mixed Financial Results for 2025
Premium
Company Announcements
XVIVO Perfusion AB Reports Mixed Financial Results for 2025
6M ago
XVIVO Perfusion AB Reports Mixed Financial Results Amid Strategic Investments
PremiumCompany Announcements
XVIVO Perfusion AB Reports Mixed Financial Results Amid Strategic Investments
6M ago
XVIPF Earnings this Week: How Will it Perform?
PremiumPre-Earnings
XVIPF Earnings this Week: How Will it Perform?
6M ago
Xvivo Perfusion reports CE approval delay for perfusion solution and supplement
PremiumThe Fly
Xvivo Perfusion reports CE approval delay for perfusion solution and supplement
9M ago
XVIVO Faces Delay in CE Approval for Heart Perfusion Solution
PremiumCompany Announcements
XVIVO Faces Delay in CE Approval for Heart Perfusion Solution
9M ago
XVIVO Initiates US PRESERVE CAP Study for Heart Assist Device
PremiumCompany AnnouncementsXVIVO Initiates US PRESERVE CAP Study for Heart Assist Device
9M ago
Xvivo Perfusion upgraded to Buy from Hold at DNB Carnegie
Premium
The Fly
Xvivo Perfusion upgraded to Buy from Hold at DNB Carnegie
9M ago
XVIVO Perfusion AB Reports Mixed Results Amid Strategic Growth
Premium
Company Announcements
XVIVO Perfusion AB Reports Mixed Results Amid Strategic Growth
9M ago

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >